Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Coronary Artery Disease Interventions: Device: DCB in large de novo coronary lesions guided by IVUS and AngioFFR; Device: DES in large de novo coronary lesions guided by IVUS and AngioFFR Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang...

Alternative Peripheral TAVI Accesses

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Aortic Stenosis Interventions: Procedure: TAVI procedures with an alternative access Sponsors: Medical University of Silesia Not yet recruiting Conditions: Aortic Stenosis Interventions: Procedure: TAVI procedures with an alternative access Sponsors:...

Myopia Control Using Novel Soft Contact Lenses

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Myopia Interventions: Other: Lens A; Other: Lens B Sponsors: The Hong Kong Polytechnic University; Eyebright Medical Technology (Beijing) Co., Ltd. Not yet recruiting Conditions: Myopia Interventions: Other: Lens A; Other: Lens B Sponsors: The Hong Kong...

Effects of Developmental Support for Mothers of Infants With Spinal Muscular Atrophy

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Spinal Muscular Atrophy; Developmental Delay Interventions: Behavioral: Online Early Intervention Program for Infants with SMA Type 1; Other: Standard Care Sponsors: Medipol University; Istanbul Medipol University Hospital Active, not...

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Early Breast Cancer Interventions: Drug: Giredestrant Sponsors: Genentech, Inc. Not yet recruiting Conditions: Early Breast Cancer Interventions: Drug: Giredestrant Sponsors: Genentech, Inc. Not yet...

Cognitive Function and Affective Regulation in Meditators

by palligoelme@gmail.com | Apr 23, 2026 | Clinical Trials

​ Conditions: Cognitive Function and Affective Regulation Sponsors: Balachundhar Subramaniam Recruiting Conditions: Cognitive Function and Affective Regulation Sponsors: Balachundhar Subramaniam Recruiting